- Home
- RCKT vs RNST Comparison
RCKT vs RNST Comparison
Compare RCKT & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- RNST
- Stock Information
- Founded
- RCKT 1999
- RNST 1904
- Country
- RCKT United States
- RNST United States
- Employees
- RCKT N/A
- RNST N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- RNST Major Banks
- Sector
- RCKT Health Care
- RNST Finance
- Exchange
- RCKT Nasdaq
- RNST Nasdaq
- Market Cap
- RCKT 328.6M
- RNST 3.7B
- IPO Year
- RCKT N/A
- RNST N/A
- Fundamental
- Price
- RCKT $3.03
- RNST $37.78
- Analyst Decision
- RCKT Buy
- RNST Buy
- Analyst Count
- RCKT 13
- RNST 6
- Target Price
- RCKT $12.96
- RNST $42.20
- AVG Volume (30 Days)
- RCKT 5.7M
- RNST 515.2K
- Earning Date
- RCKT 11-06-2025
- RNST 10-21-2025
- Dividend Yield
- RCKT N/A
- RNST 2.33%
- EPS Growth
- RCKT N/A
- RNST N/A
- EPS
- RCKT N/A
- RNST 2.24
- Revenue
- RCKT N/A
- RNST $735,575,000.00
- Revenue This Year
- RCKT N/A
- RNST $42.66
- Revenue Next Year
- RCKT $108.43
- RNST $12.60
- P/E Ratio
- RCKT N/A
- RNST $16.86
- Revenue Growth
- RCKT N/A
- RNST 17.23
- 52 Week Low
- RCKT $2.19
- RNST $26.97
- 52 Week High
- RCKT $22.01
- RNST $40.40
- Technical
- Relative Strength Index (RSI)
- RCKT 42.39
- RNST 45.88
- Support Level
- RCKT $3.09
- RNST $37.10
- Resistance Level
- RCKT $3.29
- RNST $39.10
- Average True Range (ATR)
- RCKT 0.17
- RNST 0.87
- MACD
- RCKT -0.03
- RNST -0.23
- Stochastic Oscillator
- RCKT 0.00
- RNST 20.61
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.